Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation
June 4, 2024
Providing rights to academic research globally aimed at enabling solutions to complex challenges and driving sustainability in food and agriculture Expanding the potential of CRISPR-based technologies through the collaborative innovation platform Shoots by Syngenta Syngenta Group, one of the world’s largest agricultural technology companies, will provide rights to selected genome-editing and breeding technologies for [...]
AmpleLogic Launches Advanced aPaaS for Life Sciences with 14 Ready-to-Use Applications
June 4, 2024
HYDERABAD, India -- AmpleLogic, a leading provider of GAMP solutions, announces the launch of its revolutionary Application Platform as a Service (aPaaS) designed specifically for the life sciences sector. This cutting-edge platform leverages low-code/no-code technology to accelerate digitization in life sciences industry while enhancing operational efficiency and ensuring compliance with regulatory standards from USFDA, MHRA, EMEA, ISO, and [...]
New Duplex-Specific Nuclease (DSN): Most Selective dsDNase
June 4, 2024
ZYMO RESEARCH UNVEILS PUREREC DSN: THE MOST SELECTIVE DUPLEX-SPECIFIC NUCLEASE IRVINE, Calif. — Zymo Research, a leader in biotechnological advancement has launched a new nuclease called PureRec Duplex-Specific Nuclease (DSN) that selectively digests double stranded DNA (dsDNA). This new PureRec DSN promises unparalleled specificity in targeting duplex DNA, unlocking a variety of potential applications. DSN selectively digests dsDNA [...]
June 4, 2024
WILMINGTON, Del. -- LabWare, a global leader in Laboratory Information Management Systems (LIMS) within the Pharma and BioPharma industry, last month played a key role in spearheading and guiding an exploratory delegation led by the Governor of Delaware to investigate and exchange opportunities within Ireland's BioPharma sector. This visit focused on Ireland's success in biopharmaceutical manufacturing, fostering collaborations, exploring innovation, and leveraging valuable insights [...]
Allen Institute for Cell Science launches first disease-specific cell line collections
June 4, 2024
New tools will advance study—and hopefully treatment—of common genetic heart conditions. For every 500 people reading this, one likely has a disease called hypertrophic cardiomyopathy (HCM). It is the most common genetic heart condition in the world, primarily caused by mutations that thicken heart muscle and, in rare cases, lead to heart failure and cardiac [...]
Saguaro Biosciences Secures $3M in Seed Funding to Transform Cell Biology Research
June 4, 2024
QUEBEC CITY -- Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive grant funding. The funding round was led by AQC Capital and Anges Québec, featuring significant contributions from notable figures including Martin Leblanc, [...]
Aragen Bioscience Validates Getinge’s Single-Use Production Reactor (SUPR)
June 4, 2024
GMP-compliant 50L and 250L SUPRs support large-scale recombinant antibody production Morgan Hill, USA and Delft, Netherlands: Aragen Bioscience, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, and Getinge, a Swedish life sciences products and solutions provider, today announced the successful validation of latter’s Single-Use Production Reactors (SUPR) for large-scale recombinant [...]
SPT Labtech brings the power of miniaturization to more genomics researchers with mosquito® Gen3
June 4, 2024
This new instrument delivers automated true positive displacement technology in an exceptionally compact footprint Cambridge, UK – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, has expanded its nanoliter liquid handling portfolio with the launch of mosquito Gen3. As the most compact and [...]
Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
June 4, 2024
Twist joins leading AI stakeholders to help advance the development and deployment of safe, trustworthy AI under new U.S. Government safety institute SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that the company has joined the U.S. AI [...]
Trilantic North America Completes Strategic Growth Investment in SOFIE Biosciences
June 4, 2024
NEW YORK – Trilantic North America, a growth-focused middle market private equity firm, announced today that it has made a substantial growth investment in SOFIE Biosciences (“SOFIE” or the “Company”), a founder-led radiopharmacy and contract development and manufacturing organization. The investment was made in partnership with SOFIE’s founding team, who will retain a meaningful equity [...]

